Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer.

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q46351405
At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneThe Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patientsTumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer.Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II TrialExpression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma.MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.The epidermal growth factor receptor: a link between inflammation and liver cancer.Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alpha.Lentivirus-mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro.Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer.Lentivirus-mediated silencing of HOTAIR lncRNA restores gefitinib sensitivity by activating Bax/Caspase-3 and suppressing TGF-α/EGFR signaling in lung adenocarcinoma.TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy.Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors.
P2860

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q46351405
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Clinical significance of pretr ...... s, non-small cell lung cancer.
@en
Clinical significance of pretr ...... s, non-small cell lung cancer.
@nl
type
label
Clinical significance of pretr ...... s, non-small cell lung cancer.
@en
Clinical significance of pretr ...... s, non-small cell lung cancer.
@nl
prefLabel
Clinical significance of pretr ...... s, non-small cell lung cancer.
@en
Clinical significance of pretr ...... s, non-small cell lung cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Clinical significance of pretr ...... s, non-small cell lung cancer.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1349-7006.2008.00931.X
P433
P478
P577
P5875
P698